What is Neuroderm, A Mitsubishi Tanabe Pharma Group Company's official website?

Neuroderm, A Mitsubishi Tanabe Pharma Group Company's website is neuroderm.com

How many employees are working in Neuroderm, A Mitsubishi Tanabe Pharma Group Company right now?

Neuroderm, A Mitsubishi Tanabe Pharma Group Company has 170 employees.

Who are Neuroderm, A Mitsubishi Tanabe Pharma Group Company's top competitors?

Neuroderm, A Mitsubishi Tanabe Pharma Group Company's top competitors are , , , , , ,

Neuroderm, A Mitsubishi Tanabe Pharma Group Company company information, Employees & Contact Information

Q: What is Neuroderm, A Mitsubishi Tanabe Pharma Group Company's industry?

Neuroderm, A Mitsubishi Tanabe Pharma Group Company's industry is Pharmaceutical Manufacturing

Explore related pages

Neuroderm, A Mitsubishi Tanabe Pharma Group Company email format Neuroderm, A Mitsubishi Tanabe Pharma Group Company management contacts

Related company profiles:

NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration. By developing next-generation drug-device combination solutions for central nervous system disorders, we aspire to make a meaningful difference in patients’ lives and drive future healthcare connectivity. Our mission is to address the challenges of the future healthcare and wellbeing ecosystem. We are passionately driven to reduce disease burden and improve the quality of life of patients and their families through innovative drug-device combination therapies and technologies.

Employees: 170
Founded: -
Address: 3 Pekeris Street, Rehovot,7670212,israel
Phone: +972 8-946-2729
Industry: Pharmaceutical Manufacturing
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

In-Vitro Diagnostic Substance Manufacturing

Biological Product (except Diagnostic) Manufacturing
Website: neuroderm.com
Keywords: professionals..
HQ: Rehovot
Competitors: Medtronic, Evogene, CollPlant, Mitsubishi Tanabe Pharma America, Vectorious Medical Technologies, MediWound, NeuroSense Therapeutics, INSIGHTEC, Mitsubishi Tanabe Pharma Corporation, BioLineRx.

Neuroderm, A Mitsubishi Tanabe Pharma Group Company Questions

News

NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations - PR Newswire

NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations PR Newswire

Parkinson Therapy ND0612 Receives Complete Response Letter - NeurologyLive

Parkinson Therapy ND0612 Receives Complete Response Letter NeurologyLive

AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24 - BioSpace

AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24 BioSpace

NeuroDerm Enters Definitive Agreement to be Acquired by - GlobeNewswire

NeuroDerm Enters Definitive Agreement to be Acquired by GlobeNewswire

AAN 2024: AbbVie and NeuroDerm highlight benefits of levodopa infusions in hope of US launch - Clinical Trials Arena

AAN 2024: AbbVie and NeuroDerm highlight benefits of levodopa infusions in hope of US launch Clinical Trials Arena

Mitsubishi unit buys Israel’s NeuroDerm - ACS Publications

Mitsubishi unit buys Israel’s NeuroDerm ACS Publications

Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion - CHEManager

Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion CHEManager

Mitsubishi Tanabe to acquire NeuroDerm for $1.1B - BioPharma Dive

Mitsubishi Tanabe to acquire NeuroDerm for $1.1B BioPharma Dive

Mitsubishi Tanabe buys up NeuroDerm in $1.1B deal - Fierce Biotech

Mitsubishi Tanabe buys up NeuroDerm in $1.1B deal Fierce Biotech

NeuroDerm shares positive phase 3 results for investigational Parkinson’s disease therapy - PMLiVE

NeuroDerm shares positive phase 3 results for investigational Parkinson’s disease therapy PMLiVE

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future - Nature

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future Nature

Mitsubishi Tanabe Pharma to Buy Israel's Neuroderm for $1.1 Billion - Fortune

Mitsubishi Tanabe Pharma to Buy Israel's Neuroderm for $1.1 Billion Fortune

Israeli drug maker NeuroDerm sold to Japanese pharma giant for $1.1b - The Times of Israel

Israeli drug maker NeuroDerm sold to Japanese pharma giant for $1.1b The Times of Israel

Israel’s NeuroDerm to be sold for $1.1 billion - Unpacked

Israel’s NeuroDerm to be sold for $1.1 billion Unpacked

Patent update: Neuroderm improves the design for its wearable anti-Parkinson’s infusion pump - BioWorld MedTech

Patent update: Neuroderm improves the design for its wearable anti-Parkinson’s infusion pump BioWorld MedTech

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm - CTech

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm CTech

BeyoND Phase 2b Data Indicates ND0612 Has a Positive Long-Term Safety Profile for People with Parkinson's Disease - PR Newswire

BeyoND Phase 2b Data Indicates ND0612 Has a Positive Long-Term Safety Profile for People with Parkinson's Disease PR Newswire

ND0612 Reduces OFF Time for Motor Fluctuations in Parkinson Disease at 12 Months - NeurologyLive

ND0612 Reduces OFF Time for Motor Fluctuations in Parkinson Disease at 12 Months NeurologyLive

NeuroDerm's minipump passes the patient test - Fierce Biotech

NeuroDerm's minipump passes the patient test Fierce Biotech

NeuroDerm Announces Publication of Positive Results from Phase 3 BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations - PR Newswire

NeuroDerm Announces Publication of Positive Results from Phase 3 BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations PR Newswire

Israeli Medi Tech Firm NeuroDerm Sold to Japanese Firm for Whopping $1.1 Billion - Haaretz

Israeli Medi Tech Firm NeuroDerm Sold to Japanese Firm for Whopping $1.1 Billion Haaretz

Phase 3 Parkinson's Trial Design of NeuroDerm's ND0612 Gets EMA Nod - Parkinson's News Today

Phase 3 Parkinson's Trial Design of NeuroDerm's ND0612 Gets EMA Nod Parkinson's News Today

NeuroDerm's subcutaneously delivered alternative to oral levodopa shows promise in Parkinson's trial - Fierce Pharma

NeuroDerm's subcutaneously delivered alternative to oral levodopa shows promise in Parkinson's trial Fierce Pharma

The $1 billion Israeli technology to help regulate Parkinson’s disease - The Jerusalem Post

The $1 billion Israeli technology to help regulate Parkinson’s disease The Jerusalem Post

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion - CTech

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion CTech

Israeli pharma co NeuroDerm sold for $1.1b - Globes - Israel Business News

Israeli pharma co NeuroDerm sold for $1.1b Globes - Israel Business News

NeuroDerm sold for $1.1B in Israeli pharma industry's largest deal - ישראל היום

NeuroDerm sold for $1.1B in Israeli pharma industry's largest deal ישראל היום

Companies like Neuroderm, A Mitsubishi Tanabe Pharma Group Company

Top Neuroderm, A Mitsubishi Tanabe Pharma Group Company Employees

Anat Nahmany

n/a

Israel, Israel

View

1
netvision.net.il
Hagit Amar

Cmc Analytical Project Manager At…

Israel, Israel

View

1
gmail.com
Oleksii Yerko

Consultant, Operations At Neuroderm Ltd.

Ukraine, Ukraine

View

1
neuroderm.com
Olga Kaganovich

Sw Qa Engineer At Neuroderm

Israel, Israel

View

2
yandex.ru, spiceboxlabs.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Neuroderm, A Mitsubishi Tanabe Pharma Group Company company information, Employees & Contact Information

Explore related pages

Company Details

Neuroderm, A Mitsubishi Tanabe Pharma Group Company Questions

What is Neuroderm, A Mitsubishi Tanabe Pharma Group Company's helpline number?

What is Neuroderm, A Mitsubishi Tanabe Pharma Group Company's official website?

What is Neuroderm, A Mitsubishi Tanabe Pharma Group Company's LinkedIn profile?

How many employees are working in Neuroderm, A Mitsubishi Tanabe Pharma Group Company right now?

What is Neuroderm, A Mitsubishi Tanabe Pharma Group Company's industry?

What are Neuroderm, A Mitsubishi Tanabe Pharma Group Company's top competitors?

What are Neuroderm, A Mitsubishi Tanabe Pharma Group Company's categories?

When was Neuroderm, A Mitsubishi Tanabe Pharma Group Company founded?

News

NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations - PR Newswire

Parkinson Therapy ND0612 Receives Complete Response Letter - NeurologyLive

AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24 - BioSpace

NeuroDerm Enters Definitive Agreement to be Acquired by - GlobeNewswire

AAN 2024: AbbVie and NeuroDerm highlight benefits of levodopa infusions in hope of US launch - Clinical Trials Arena

Mitsubishi unit buys Israel’s NeuroDerm - ACS Publications

Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion - CHEManager

Mitsubishi Tanabe to acquire NeuroDerm for $1.1B - BioPharma Dive

Mitsubishi Tanabe buys up NeuroDerm in $1.1B deal - Fierce Biotech

NeuroDerm shares positive phase 3 results for investigational Parkinson’s disease therapy - PMLiVE

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future - Nature

Mitsubishi Tanabe Pharma to Buy Israel's Neuroderm for $1.1 Billion - Fortune

Israeli drug maker NeuroDerm sold to Japanese pharma giant for $1.1b - The Times of Israel

Israel’s NeuroDerm to be sold for $1.1 billion - Unpacked

Patent update: Neuroderm improves the design for its wearable anti-Parkinson’s infusion pump - BioWorld MedTech

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm - CTech

BeyoND Phase 2b Data Indicates ND0612 Has a Positive Long-Term Safety Profile for People with Parkinson's Disease - PR Newswire

ND0612 Reduces OFF Time for Motor Fluctuations in Parkinson Disease at 12 Months - NeurologyLive

NeuroDerm's minipump passes the patient test - Fierce Biotech

NeuroDerm Announces Publication of Positive Results from Phase 3 BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations - PR Newswire

Israeli Medi Tech Firm NeuroDerm Sold to Japanese Firm for Whopping $1.1 Billion - Haaretz

Phase 3 Parkinson's Trial Design of NeuroDerm's ND0612 Gets EMA Nod - Parkinson's News Today

NeuroDerm's subcutaneously delivered alternative to oral levodopa shows promise in Parkinson's trial - Fierce Pharma

The $1 billion Israeli technology to help regulate Parkinson’s disease - The Jerusalem Post

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion - CTech

Israeli pharma co NeuroDerm sold for $1.1b - Globes - Israel Business News

NeuroDerm sold for $1.1B in Israeli pharma industry's largest deal - ישראל היום

Companies like Neuroderm, A Mitsubishi Tanabe Pharma Group Company

Vectorious Medical T...

Mitsubishi Tanabe Ph...

Evogene

Neurosense Therapeutics

Collplant

Mediwound

Insightec

Medtronic

Mitsubishi Tanabe Ph...

Biolinerx

Top Neuroderm, A Mitsubishi Tanabe Pharma Group Company Employees

Anat Nahmany

n/a

Hagit Amar

Cmc Analytical Project Manager At…

Oleksii Yerko

Consultant, Operations At Neuroderm Ltd.

Olga Kaganovich

Sw Qa Engineer At Neuroderm

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data